SIMILAR PATTERNS OF AMINO ACIDS FOR 1MUI_B_AB1B100_2
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1bqc | PROTEIN(BETA-MANNANASE) (Thermobifidafusca) |
PF00150(Cellulase) | 5 | GLY A 227ILE A 195GLY A 224ILE A 252ILE A 240 | None | 0.83A | 1muiB-1bqcA:0.0 | 1muiB-1bqcA:17.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1g0v | PROTEASE A INHIBITOR3PROTEINASE A (Saccharomycescerevisiae) |
PF00026(Asp)PF10466(Inhibitor_I34) | 5 | ASP A 32GLY A 34ILE A 73GLY B 21ILE A 120 | None | 0.87A | 1muiB-1g0vA:7.5 | 1muiB-1g0vA:16.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1gz5 | ALPHA-TREHALOSE-PHOSPHATE SYNTHASE (Escherichiacoli) |
PF00982(Glyco_transf_20) | 5 | GLY A 389ALA A 390ILE A 434GLY A 226ILE A 225 | NoneNoneNoneNoneIMD A 902 ( 4.3A) | 0.84A | 1muiB-1gz5A:undetectable | 1muiB-1gz5A:15.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1h4p | GLUCAN1,3-BETA-GLUCOSIDASEI/II (Saccharomycescerevisiae) |
PF00150(Cellulase) | 5 | ALA A 421ASP A 420GLY A 59ILE A 58ILE A 408 | None | 0.88A | 1muiB-1h4pA:undetectable | 1muiB-1h4pA:16.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | ARG A 8ASP A 25ASP A 29GLY A 49ILE A 50PRO A 81 | A79 A 800 (-3.6A)A79 A 800 (-2.8A)A79 A 800 (-2.7A)A79 A 800 (-3.4A)A79 A 800 ( 4.0A)A79 A 800 ( 3.4A) | 1.41A | 1muiB-1hvcA:18.0 | 1muiB-1hvcA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | ARG A 8ASP A 25GLY A 49ILE A 50PRO A 81VAL A 82 | A79 A 800 (-3.6A)A79 A 800 (-2.8A)A79 A 800 (-3.4A)A79 A 800 ( 4.0A)A79 A 800 ( 3.4A)A79 A 800 (-4.5A) | 0.69A | 1muiB-1hvcA:18.0 | 1muiB-1hvcA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 7 | ASP A 25ALA A 28ASP A 29GLY A 48PRO A 81VAL A 82ILE A 84 | A79 A 800 (-2.8A)A79 A 800 (-3.2A)A79 A 800 (-2.7A)A79 A 800 (-4.1A)A79 A 800 ( 3.4A)A79 A 800 (-4.5A)A79 A 800 (-3.8A) | 0.85A | 1muiB-1hvcA:18.0 | 1muiB-1hvcA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | ASP A 25ALA A 28ASP A 29GLY A 49ILE A 50PRO A 81 | A79 A 800 (-2.8A)A79 A 800 (-3.2A)A79 A 800 (-2.7A)A79 A 800 (-3.4A)A79 A 800 ( 4.0A)A79 A 800 ( 3.4A) | 1.33A | 1muiB-1hvcA:18.0 | 1muiB-1hvcA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 11 | ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30ILE A 47GLY A 49ILE A 50PRO A 81VAL A 82ILE A 84 | A79 A 800 (-2.7A)A79 A 800 (-3.0A)A79 A 800 (-3.1A)A79 A 800 (-2.8A)A79 A 800 ( 4.9A)A79 A 800 ( 3.2A)A79 A 800 ( 3.7A)A79 A 800 (-3.8A)A79 A 800 ( 3.9A)A79 A 800 (-4.5A)A79 A 800 (-3.6A) | 0.59A | 1muiB-1hvcA:18.0 | 1muiB-1hvcA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 11 | ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30ILE A 47GLY A 49ILE A 50PRO A 81VAL A 82ILE A 84 | A79 A 800 (-2.8A)A79 A 800 (-3.0A)A79 A 800 (-3.2A)A79 A 800 (-2.7A)A79 A 800 ( 4.7A)A79 A 800 ( 3.4A)A79 A 800 (-3.4A)A79 A 800 ( 4.0A)A79 A 800 ( 3.4A)A79 A 800 (-4.5A)A79 A 800 (-3.8A) | 0.48A | 1muiB-1hvcA:18.0 | 1muiB-1hvcA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 7 | ASP A 25GLY A 27ALA A 28ASP A 29GLY A 48VAL A 82ILE A 84 | A79 A 800 (-2.7A)A79 A 800 (-3.0A)A79 A 800 (-3.1A)A79 A 800 (-2.8A)A79 A 800 (-3.6A)A79 A 800 (-4.5A)A79 A 800 (-3.6A) | 0.78A | 1muiB-1hvcA:18.0 | 1muiB-1hvcA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1kae | HISTIDINOLDEHYDROGENASE (Escherichiacoli) |
PF00815(Histidinol_dh) | 5 | GLY A 227ALA A 228ASP A 204GLY A 196ILE A 206 | None | 0.88A | 1muiB-1kaeA:undetectable | 1muiB-1kaeA:13.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1khd | ANTHRANILATEPHOSPHORIBOSYLTRANSFERASE (Pectobacteriumcarotovorum) |
PF00591(Glycos_transf_3)PF02885(Glycos_trans_3N) | 5 | GLY A 67ALA A 68ILE A 38ILE A 16ILE A 186 | None | 0.85A | 1muiB-1khdA:undetectable | 1muiB-1khdA:15.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1lk5 | D-RIBOSE-5-PHOSPHATEISOMERASE (Pyrococcushorikoshii) |
PF06026(Rib_5-P_isom_A) | 5 | GLY A 101ALA A 102GLY A 207ILE A 97ILE A 179 | CL A1001 (-3.4A)NoneNoneNoneNone | 0.85A | 1muiB-1lk5A:undetectable | 1muiB-1lk5A:18.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1llu | ALCOHOLDEHYDROGENASE (Pseudomonasaeruginosa) |
PF00107(ADH_zinc_N)PF08240(ADH_N) | 5 | GLY A 42ILE A 64GLY A 119VAL A 36ILE A 38 | None | 0.77A | 1muiB-1lluA:undetectable | 1muiB-1lluA:15.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1q33 | ADP-RIBOSEPYROPHOSPHATASE (Homo sapiens) |
PF00293(NUDIX) | 6 | GLY A 303ALA A 306ASP A 305GLY A 215VAL A 200ILE A 202 | NoneNoneNoneBGC A 400 (-3.3A)NoneNone | 1.40A | 1muiB-1q33A:undetectable | 1muiB-1q33A:19.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1q9p | HIV-1 PROTEASE (Homo sapiens) |
PF00077(RVP) | 7 | ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30PRO A 81ILE A 84 | None | 0.81A | 1muiB-1q9pA:10.5 | 1muiB-1q9pA:94.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1rjw | ALCOHOLDEHYDROGENASE (Geobacillusstearothermophilus) |
PF00107(ADH_zinc_N)PF08240(ADH_N) | 6 | GLY A 36ALA A 144ILE A 134GLY A 84ILE A 85VAL A 151 | None | 1.29A | 1muiB-1rjwA:undetectable | 1muiB-1rjwA:17.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1rvv | RIBOFLAVIN SYNTHASE (Bacillussubtilis) |
no annotation | 6 | GLY A 33ALA A 34ILE A 112GLY A 114VAL A 50ILE A 17 | None | 1.48A | 1muiB-1rvvA:undetectable | 1muiB-1rvvA:28.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1siv | SIV PROTEASE (Simianimmunodeficiencyvirus) |
PF00077(RVP) | 8 | ARG A 8ASP A 25ALA A 28ASP A 29GLY A 49ILE A 50PRO A 81ILE A 84 | None | 1.26A | 1muiB-1sivA:18.4 | 1muiB-1sivA:50.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1siv | SIV PROTEASE (Simianimmunodeficiencyvirus) |
PF00077(RVP) | 10 | ARG A 8ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30GLY A 49ILE A 50PRO A 81ILE A 84 | None | 0.55A | 1muiB-1sivA:18.4 | 1muiB-1sivA:50.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1siv | SIV PROTEASE (Simianimmunodeficiencyvirus) |
PF00077(RVP) | 7 | ASP A 25GLY A 27ALA A 28ASP A 29GLY A 48PRO A 81ILE A 84 | None | 0.80A | 1muiB-1sivA:18.4 | 1muiB-1sivA:50.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1xa0 | PUTATIVE NADPHDEPENDENTOXIDOREDUCTASES (Geobacillusstearothermophilus) |
PF00107(ADH_zinc_N) | 5 | GLY A 131ALA A 130ILE A 66ILE A 87VAL A 324 | NoneSO4 A 329 ( 4.2A)NoneNoneNone | 0.75A | 1muiB-1xa0A:undetectable | 1muiB-1xa0A:17.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1yr2 | PROLYLOLIGOPEPTIDASE (Novosphingobiumcapsulatum) |
PF00326(Peptidase_S9)PF02897(Peptidase_S9_N) | 6 | GLY A 539ALA A 538ASP A 537GLY A 529PRO A 475VAL A 474 | None | 1.02A | 1muiB-1yr2A:undetectable | 1muiB-1yr2A:8.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1zno | HYPOTHETICAL UPF0244PROTEIN VC0702 (Vibrio cholerae) |
PF01931(NTPase_I-T) | 5 | ARG A 74GLY A 77ALA A 78VAL A 44ILE A 14 | None | 0.84A | 1muiB-1znoA:undetectable | 1muiB-1znoA:19.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2b4q | RHAMNOLIPIDSBIOSYNTHESIS3-OXOACYL-[ACYL-CARRIER-PROTEIN]REDUCTASE (Pseudomonasaeruginosa) |
PF13561(adh_short_C2) | 5 | GLY A 237ALA A 236ILE A 25GLY A 28ILE A 88 | None | 0.82A | 1muiB-2b4qA:undetectable | 1muiB-2b4qA:18.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2bc0 | NADH OXIDASE (Streptococcuspyogenes) |
PF02852(Pyr_redox_dim)PF07992(Pyr_redox_2) | 5 | GLY A 453ALA A 454ASP A 456ILE A 387ILE A 426 | None | 0.65A | 1muiB-2bc0A:undetectable | 1muiB-2bc0A:12.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2bkl | PROLYL ENDOPEPTIDASE (Myxococcusxanthus) |
PF00326(Peptidase_S9)PF02897(Peptidase_S9_N) | 6 | GLY A 497ALA A 496ASP A 495GLY A 487PRO A 431VAL A 430 | None | 1.04A | 1muiB-2bklA:undetectable | 1muiB-2bklA:10.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2c1d | SOXASOXX (Paracoccusdenitrificans;Paracoccuspantotrophus) |
PF00034(Cytochrom_C)no annotation | 5 | ARG A 219GLY B 49ILE B 52VAL B 73ILE B 67 | None | 0.87A | 1muiB-2c1dA:undetectable | 1muiB-2c1dA:15.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2dpm | PROTEIN(ADENINE-SPECIFICMETHYLTRANSFERASEDPNII 1) (Streptococcuspneumoniae) |
PF02086(MethyltransfD12) | 5 | GLY A 47ASP A 62ILE A 68ILE A 74ILE A 60 | SAM A 300 (-4.5A)SAM A 300 (-2.8A)NoneNoneNone | 0.89A | 1muiB-2dpmA:undetectable | 1muiB-2dpmA:17.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2eyq | TRANSCRIPTION-REPAIRCOUPLING FACTOR (Escherichiacoli) |
PF00270(DEAD)PF00271(Helicase_C)PF02559(CarD_CdnL_TRCF)PF03461(TRCF) | 5 | ARG A1029ASP A1015GLY A1051ILE A1047ILE A1017 | None | 0.89A | 1muiB-2eyqA:undetectable | 1muiB-2eyqA:7.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ffu | POLYPEPTIDEN-ACETYLGALACTOSAMINYLTRANSFERASE 2 (Homo sapiens) |
PF00535(Glycos_transf_2)PF00652(Ricin_B_lectin) | 5 | GLY A 308ALA A 307ILE A 351VAL A 357ILE A 253 | None | 0.89A | 1muiB-2ffuA:undetectable | 1muiB-2ffuA:10.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2fmb | EQUINE INFECTIOUSANEMIA VIRUSPROTEASE (Equineinfectiousanemia virus) |
PF00077(RVP) | 9 | ARG A 8ASP A 25GLY A 27ALA A 28ASP A 29ILE A 53GLY A 55PRO A 86ILE A 89 | LP1 A 201 (-3.5A)LP1 A 201 (-2.3A)LP1 A 201 (-3.8A)LP1 A 201 (-3.5A)LP1 A 201 (-3.6A)LP1 A 201 (-4.6A)LP1 A 201 (-3.4A)LP1 A 201 (-3.9A)LP1 A 201 (-4.2A) | 0.56A | 1muiB-2fmbA:15.1 | 1muiB-2fmbA:30.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2fmb | EQUINE INFECTIOUSANEMIA VIRUSPROTEASE (Equineinfectiousanemia virus) |
PF00077(RVP) | 6 | ASP A 25GLY A 27ALA A 28ASP A 29GLY A 54ILE A 89 | LP1 A 201 (-2.3A)LP1 A 201 (-3.8A)LP1 A 201 (-3.5A)LP1 A 201 (-3.6A)LP1 A 201 (-3.6A)LP1 A 201 (-4.2A) | 0.79A | 1muiB-2fmbA:15.1 | 1muiB-2fmbA:30.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2fmb | EQUINE INFECTIOUSANEMIA VIRUSPROTEASE (Equineinfectiousanemia virus) |
PF00077(RVP) | 9 | ASP A 25GLY A 27ALA A 28ASP A 29ILE A 53GLY A 55PRO A 86VAL A 87ILE A 89 | LP1 A 201 (-2.3A)LP1 A 201 (-3.8A)LP1 A 201 (-3.5A)LP1 A 201 (-3.6A)LP1 A 201 (-4.6A)LP1 A 201 (-3.4A)LP1 A 201 (-3.9A)LP1 A 201 ( 4.9A)LP1 A 201 (-4.2A) | 0.53A | 1muiB-2fmbA:15.1 | 1muiB-2fmbA:30.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2i1n | DISCS, LARGE HOMOLOG3 (Homo sapiens) |
PF00595(PDZ) | 6 | GLY A 142ALA A 171ASP A 174ILE A 132VAL A 179ILE A 165 | None | 1.31A | 1muiB-2i1nA:undetectable | 1muiB-2i1nA:16.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2isq | CYSTEINE SYNTHASE (Arabidopsisthaliana) |
PF00291(PALP) | 5 | GLY A 190ALA A 189GLY A 183ILE A 180PRO A 296 | NoneNonePLP A 400 (-3.4A)PLP A 400 (-4.9A)PLP A 400 (-4.0A) | 0.73A | 1muiB-2isqA:undetectable | 1muiB-2isqA:15.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2q5e | CARBOXY-TERMINALDOMAIN RNAPOLYMERASE IIPOLYPEPTIDE A SMALLPHOSPHATASE 2 (Homo sapiens) |
PF03031(NIF) | 6 | GLY A 257ALA A 258ASP A 260ILE A 251VAL A 104ILE A 102 | None | 1.43A | 1muiB-2q5eA:undetectable | 1muiB-2q5eA:17.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qua | EXTRACELLULAR LIPASE (Serratiamarcescens) |
no annotation | 6 | ARG A 454ALA A 447ASP A 448GLY A 392ILE A 381ILE A 450 | NoneNoneNone CA A 619 (-4.2A)NoneNone | 1.22A | 1muiB-2quaA:undetectable | 1muiB-2quaA:9.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2rkf | PROTEASE RETROPEPSIN (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 7 | ARG A 8ASP A 25ALA A 28ASP A 29GLY A 49PRO A 81ILE A 84 | AB1 A 501 ( 4.7A)AB1 A 501 (-2.4A)AB1 A 501 (-3.5A)AB1 A 501 ( 3.3A)AB1 A 501 (-3.5A)AB1 A 501 (-4.2A)AB1 A 501 ( 4.2A) | 1.39A | 1muiB-2rkfA:21.2 | 1muiB-2rkfA:87.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2rkf | PROTEASE RETROPEPSIN (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 10 | ARG A 8ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30GLY A 49ILE A 50PRO A 81ILE A 84 | AB1 A 501 ( 4.7A)AB1 A 501 (-2.4A)AB1 A 501 (-3.9A)AB1 A 501 (-3.5A)AB1 A 501 ( 3.3A)AB1 A 501 (-3.8A)AB1 A 501 (-3.5A)AB1 A 501 (-3.8A)AB1 A 501 (-4.2A)AB1 A 501 ( 4.2A) | 0.43A | 1muiB-2rkfA:21.2 | 1muiB-2rkfA:87.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2rkf | PROTEASE RETROPEPSIN (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | GLY A 27ALA A 28ASP A 29GLY A 48PRO A 81ILE A 84 | AB1 A 501 (-3.9A)AB1 A 501 (-3.5A)AB1 A 501 ( 3.3A)AB1 A 501 (-4.2A)AB1 A 501 (-4.2A)AB1 A 501 ( 4.2A) | 0.77A | 1muiB-2rkfA:21.2 | 1muiB-2rkfA:87.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2rsp | RSV PROTEASE (Rous sarcomavirus) |
PF00077(RVP) | 6 | ARG A 10ASP A 37GLY A 39ALA A 40ASP A 41ILE A 108 | None | 0.93A | 1muiB-2rspA:12.9 | 1muiB-2rspA:32.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2y23 | MYOMESIN (Homo sapiens) |
PF07679(I-set) | 5 | ASP A1401GLY A1409ILE A1410VAL A1428ILE A1389 | None | 0.76A | 1muiB-2y23A:undetectable | 1muiB-2y23A:17.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2yrf | METHYLTHIORIBOSE-1-PHOSPHATE ISOMERASE (Bacillussubtilis) |
PF01008(IF-2B) | 6 | GLY A 238ALA A 271ILE A 334GLY A 327ILE A 325ILE A 236 | None | 1.44A | 1muiB-2yrfA:undetectable | 1muiB-2yrfA:13.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3aqp | PROBABLE SECDFPROTEIN-EXPORTMEMBRANE PROTEIN (Thermusthermophilus) |
PF02355(SecD_SecF)PF07549(Sec_GG) | 5 | GLY A 327ALA A 329GLY A 274ILE A 271VAL A 693 | None | 0.86A | 1muiB-3aqpA:undetectable | 1muiB-3aqpA:9.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3gt7 | SENSOR PROTEIN (Syntrophusaciditrophicus) |
PF00072(Response_reg) | 6 | ARG A 102GLY A 107ALA A 108ASP A 109ILE A 59VAL A 63 | None | 1.19A | 1muiB-3gt7A:undetectable | 1muiB-3gt7A:22.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3gve | YFKN PROTEIN (Bacillussubtilis) |
PF00149(Metallophos) | 5 | GLY A 121ALA A 122ASP A 123ILE A 89ILE A 126 | None | 0.79A | 1muiB-3gveA:undetectable | 1muiB-3gveA:14.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3i5g | MYOSIN HEAVY CHAINISOFORM A (Doryteuthispealeii) |
PF00063(Myosin_head)PF00612(IQ)PF02736(Myosin_N) | 6 | GLY A 264ALA A 265ASP A 266GLY A 460ILE A 459ILE A 224 | None | 1.03A | 1muiB-3i5gA:undetectable | 1muiB-3i5gA:8.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3jb9 | PRE-MRNA-SPLICINGFACTOR CWF10 (Schizosaccharomycespombe) |
PF00009(GTP_EFTU)PF00679(EFG_C)PF03144(GTP_EFTU_D2)PF03764(EFG_IV)PF16004(EFTUD2) | 6 | ALA B 461ILE B 469GLY B 467ILE B 466VAL B 489ILE B 477 | None | 1.46A | 1muiB-3jb9B:undetectable | 1muiB-3jb9B:7.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3k28 | GLUTAMATE-1-SEMIALDEHYDE 2,1-AMINOMUTASE2 (Bacillusanthracis) |
PF00202(Aminotran_3) | 5 | ALA A 125ILE A 285GLY A 281ILE A 109ILE A 238 | NoneNoneNone CA A 430 (-4.9A)None | 0.81A | 1muiB-3k28A:undetectable | 1muiB-3k28A:13.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3meq | ALCOHOLDEHYDROGENASE,ZINC-CONTAINING (Brucella suis) |
PF00107(ADH_zinc_N)PF08240(ADH_N) | 5 | GLY A 40ILE A 62GLY A 117VAL A 34ILE A 36 | None | 0.82A | 1muiB-3meqA:undetectable | 1muiB-3meqA:14.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3mst | PUTATIVE NITRATETRANSPORT PROTEIN (Thermoplasmavolcanium) |
PF12916(DUF3834) | 6 | ALA A 171ILE A 163GLY A 191ILE A 192PRO A 10ILE A 174 | NoneNoneNoneNoneACT A 232 (-4.6A)None | 1.34A | 1muiB-3mstA:undetectable | 1muiB-3mstA:18.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3mws | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 7 | ARG A 8ASP A 25ALA A 28ASP A 29GLY A 49ILE A 50PRO A 81 | None | 1.32A | 1muiB-3mwsA:19.6 | 1muiB-3mwsA:78.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3mws | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 11 | ARG A 8ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30ILE A 47GLY A 49PRO A 81VAL A 82ILE A 84 | None | 0.56A | 1muiB-3mwsA:19.6 | 1muiB-3mwsA:78.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3mws | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 11 | ARG A 8ASP A 25GLY A 27ALA A 28ASP A 29ILE A 47GLY A 49ILE A 50PRO A 81VAL A 82ILE A 84 | None | 0.55A | 1muiB-3mwsA:19.6 | 1muiB-3mwsA:78.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3mws | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 9 | ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30GLY A 48PRO A 81VAL A 82ILE A 84 | None | 0.78A | 1muiB-3mwsA:19.6 | 1muiB-3mwsA:78.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3o8l | 6-PHOSPHOFRUCTOKINASE, MUSCLE TYPE (Oryctolaguscuniculus) |
PF00365(PFK) | 6 | GLY A 224ALA A 225ASP A 226ILE A 192VAL A 207ILE A 261 | PO4 A 767 ( 4.6A)NoneNoneNoneNoneNone | 1.08A | 1muiB-3o8lA:undetectable | 1muiB-3o8lA:9.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3o8o | 6-PHOSPHOFRUCTOKINASE SUBUNIT ALPHA (Saccharomycescerevisiae) |
PF00365(PFK) | 6 | GLY A 414ALA A 415ASP A 416ILE A 382VAL A 397ILE A 452 | None | 1.23A | 1muiB-3o8oA:undetectable | 1muiB-3o8oA:8.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3opy | 6-PHOSPHOFRUCTO-1-KINASE ALPHA-SUBUNIT (Komagataellapastoris) |
PF00365(PFK) | 6 | GLY A 419ALA A 420ASP A 421ILE A 387VAL A 402ILE A 457 | None | 1.12A | 1muiB-3opyA:undetectable | 1muiB-3opyA:8.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qdf | 2-HYDROXYHEPTA-2,4-DIENE-1,7-DIOATEISOMERASE (Mycobacteriummarinum) |
PF01557(FAA_hydrolase)PF10370(DUF2437) | 5 | GLY A 100ALA A 56ILE A 177ILE A 145VAL A 63 | None | 0.88A | 1muiB-3qdfA:undetectable | 1muiB-3qdfA:20.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3rl7 | DISKS LARGE HOMOLOG1 (Homo sapiens) |
no annotation | 6 | GLY B 235ALA B 264ASP B 267ILE B 225VAL B 272ILE B 258 | None | 1.33A | 1muiB-3rl7B:undetectable | 1muiB-3rl7B:13.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3rmg | OCTAPRENYL-DIPHOSPHATE SYNTHASE (Bacteroidesthetaiotaomicron) |
PF00348(polyprenyl_synt) | 5 | ASP A 212ASP A 213GLY A 205ILE A 204ILE A 289 | None | 0.89A | 1muiB-3rmgA:undetectable | 1muiB-3rmgA:12.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3rr6 | PUTATIVEUNCHARACTERIZEDPROTEIN (Mycobacteroidesabscessus) |
PF01557(FAA_hydrolase)PF10370(DUF2437) | 5 | GLY A 97ALA A 56ILE A 174ILE A 142VAL A 63 | None | 0.90A | 1muiB-3rr6A:undetectable | 1muiB-3rr6A:19.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3s2g | ZINC-CONTAININGALCOHOLDEHYDROGENASESUPERFAMILY (Cupriaviduspinatubonensis) |
PF00107(ADH_zinc_N)PF08240(ADH_N) | 5 | GLY A 40ILE A 62GLY A 117VAL A 34ILE A 36 | None | 0.78A | 1muiB-3s2gA:undetectable | 1muiB-3s2gA:16.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3s8m | ENOYL-ACP REDUCTASE (Xanthomonasoryzae) |
PF07055(Eno-Rase_FAD_bd)PF12241(Enoyl_reductase)PF12242(Eno-Rase_NADH_b) | 5 | GLY A 213ALA A 212ILE A 206VAL A 121ILE A 122 | None | 0.76A | 1muiB-3s8mA:undetectable | 1muiB-3s8mA:15.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3t3c | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 9 | ARG A 8ASP A 25GLY A 27ALA A 28ASP A 29ILE A 47GLY A 49ILE A 50PRO A 81 | SO4 A 101 (-3.8A)017 A 201 (-2.6A)017 A 201 (-3.4A)017 A 201 (-3.5A)017 A 201 (-3.5A)None017 A 201 (-4.0A)017 A 201 (-3.3A)None | 0.89A | 1muiB-3t3cA:18.4 | 1muiB-3t3cA:77.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3t3c | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 9 | ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30ILE A 47GLY A 49ILE A 50PRO A 81 | 017 A 201 (-2.6A)017 A 201 (-3.4A)017 A 201 (-3.5A)017 A 201 (-3.5A)017 A 201 (-4.2A)None017 A 201 (-4.0A)017 A 201 (-3.3A)None | 0.75A | 1muiB-3t3cA:18.4 | 1muiB-3t3cA:77.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ttp | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 7 | ARG A 8ASP A 25ALA A 28ASP A 29GLY A 49ILE A 50PRO A 81 | 017 A 201 ( 4.8A)017 A 201 (-2.6A)017 A 201 (-3.4A)017 A 201 (-3.3A)017 A 201 (-3.0A)017 A 201 (-3.3A)017 A 201 (-4.1A) | 1.35A | 1muiB-3ttpA:19.6 | 1muiB-3ttpA:79.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ttp | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 10 | ARG A 8ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30GLY A 49ILE A 50PRO A 81ILE A 84 | 017 A 201 ( 4.8A)017 A 201 (-2.6A)017 A 201 (-3.6A)017 A 201 (-3.4A)017 A 201 (-3.3A)017 A 201 (-4.6A)017 A 201 (-3.0A)017 A 201 (-3.3A)017 A 201 (-4.1A)017 A 201 (-4.7A) | 0.48A | 1muiB-3ttpA:19.6 | 1muiB-3ttpA:79.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ttp | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | GLY A 27ALA A 28ASP A 29ASP A 30GLY A 48ILE A 84 | 017 A 201 (-3.6A)017 A 201 (-3.4A)017 A 201 (-3.3A)017 A 201 (-4.6A)None017 A 201 (-4.7A) | 0.84A | 1muiB-3ttpA:19.6 | 1muiB-3ttpA:79.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3u7s | POL POLYPROTEIN (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 10 | ARG A 8ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30ILE A 47GLY A 49ILE A 50PRO A 81 | None017 A 202 ( 2.5A)017 A 201 ( 3.5A)017 A 201 (-3.4A)017 A 201 (-3.2A)017 A 201 ( 4.0A)017 A 202 (-3.6A)017 A 202 (-2.9A)017 A 201 ( 3.5A)017 A 202 (-4.0A) | 0.46A | 1muiB-3u7sA:20.1 | 1muiB-3u7sA:79.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3uhl | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | ASP A 25GLY A 27ALA A 28ASP A 29PRO A 81VAL A 82 | None | 0.62A | 1muiB-3uhlA:16.2 | 1muiB-3uhlA:77.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3up8 | PUTATIVE2,5-DIKETO-D-GLUCONIC ACID REDUCTASE B (Sinorhizobiummeliloti) |
PF00248(Aldo_ket_red) | 6 | GLY A 8ALA A 9ASP A 100GLY A 133ILE A 153ILE A 11 | None | 1.18A | 1muiB-3up8A:undetectable | 1muiB-3up8A:19.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3vgl | GLUCOKINASE (Streptomycesgriseus) |
PF00480(ROK) | 5 | GLY A 50ALA A 51ILE A 14VAL A 60ILE A 5 | None | 0.82A | 1muiB-3vglA:undetectable | 1muiB-3vglA:18.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4aa9 | CHYMOSIN (Camelusdromedarius) |
PF00026(Asp) | 5 | ASP A 34GLY A 36ASP A 39ILE A 75ILE A 122 | NoneNoneNoneSO4 A1332 (-4.4A)None | 0.79A | 1muiB-4aa9A:8.3 | 1muiB-4aa9A:19.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4c60 | OCHRATOXINASE (Aspergillusniger) |
PF01979(Amidohydro_1) | 6 | GLY A 459ALA A 431ASP A 432GLY A 428VAL A 49ILE A 72 | None | 1.49A | 1muiB-4c60A:undetectable | 1muiB-4c60A:13.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4cw5 | DFNA (Bacillusvelezensis) |
PF03060(NMO) | 5 | GLY A 559GLY A 732ILE A 731PRO A 542ILE A 539 | FMN A1753 (-3.0A)NoneNoneNoneNone | 0.84A | 1muiB-4cw5A:undetectable | 1muiB-4cw5A:12.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4dbh | 2-HYDROXYHEPTA-2,4-DIENE-1,7-DIOATEISOMERASE (Corynebacteriumglutamicum) |
PF01557(FAA_hydrolase)PF10370(DUF2437) | 5 | GLY A 99ALA A 56ILE A 176ILE A 144VAL A 63 | None | 0.84A | 1muiB-4dbhA:undetectable | 1muiB-4dbhA:19.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4f4w | DNA POLYMERASE IV (Sulfolobusacidocaldarius;Sulfolobussolfataricus) |
PF00817(IMS)PF11798(IMS_HHH) | 5 | ALA A 96ASP A 97ASP A 110GLY A 122VAL A 6 | None | 0.85A | 1muiB-4f4wA:undetectable | 1muiB-4f4wA:15.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hyk | DNA POLYMERASE IV (Sulfolobusacidocaldarius) |
PF00817(IMS)PF11798(IMS_HHH) | 5 | ALA A 96ASP A 97ASP A 110GLY A 122VAL A 6 | None | 0.86A | 1muiB-4hykA:undetectable | 1muiB-4hykA:15.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4io1 | RIBOSE-5-PHOSPHATEISOMERASE A (Francisellatularensis) |
PF06026(Rib_5-P_isom_A) | 5 | GLY A 103ALA A 104GLY A 202ILE A 99ILE A 174 | CL A 301 (-3.5A)NoneNoneNoneNone | 0.88A | 1muiB-4io1A:undetectable | 1muiB-4io1A:20.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4iv9 | TRYPTOPHAN2-MONOOXYGENASE (Pseudomonassavastanoi) |
PF01593(Amino_oxidase) | 5 | GLY A 95ALA A 96ILE A 48GLY A 75ILE A 274 | FAD A 601 (-3.9A)FAD A 601 (-3.4A)NoneNoneNone | 0.85A | 1muiB-4iv9A:undetectable | 1muiB-4iv9A:11.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4jyj | ENOYL-COAHYDRATASE/ISOMERASE (Novosphingobiumaromaticivorans) |
PF00378(ECH_1) | 5 | ALA A 120ASP A 121ILE A 102GLY A 54ILE A 19 | None | 0.89A | 1muiB-4jyjA:undetectable | 1muiB-4jyjA:17.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ktp | GLYCOSIDE HYDROLASEFAMILY 65 CENTRALCATALYTIC ([Bacillus]selenitireducens) |
PF03632(Glyco_hydro_65m)PF03633(Glyco_hydro_65C)PF03636(Glyco_hydro_65N) | 5 | ARG A 371GLY A 376ALA A 377ILE A 420ILE A 414 | 1PE A 802 (-3.8A)NoneNoneNoneNone | 0.88A | 1muiB-4ktpA:undetectable | 1muiB-4ktpA:9.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4nfy | D-3-PHOSPHOGLYCERATEDEHYDROGENASE,PUTATIVE (Entamoebahistolytica) |
PF00389(2-Hacid_dh)PF02826(2-Hacid_dh_C) | 5 | GLY A 67ASP A 50ILE A 3ILE A 6VAL A 95 | None | 0.82A | 1muiB-4nfyA:undetectable | 1muiB-4nfyA:16.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4njv | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | ARG A 8ASP A 25ALA A 28ASP A 29GLY A 49ILE A 50 | RIT A 500 (-3.2A)RIT A 500 (-2.4A)RIT A 500 (-3.6A)RIT A 500 (-3.2A)RIT A 500 (-3.4A)RIT A 500 (-4.3A) | 1.50A | 1muiB-4njvA:20.6 | 1muiB-4njvA:87.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4njv | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 7 | ARG A 8ASP A 25GLY A 27ALA A 28GLY A 49ILE A 50ILE A 84 | RIT A 500 (-3.2A)RIT A 500 (-2.4A)RIT A 500 (-3.9A)RIT A 500 (-3.6A)RIT A 500 (-3.4A)RIT A 500 (-4.3A)RIT A 500 (-4.3A) | 0.54A | 1muiB-4njvA:20.6 | 1muiB-4njvA:87.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4njv | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 8 | ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30GLY A 48PRO A 81ILE A 84 | RIT A 500 (-2.4A)RIT A 500 (-3.9A)RIT A 500 (-3.6A)RIT A 500 (-3.2A)RIT A 500 (-4.8A)RIT A 500 (-4.8A)RIT A 500 (-3.9A)RIT A 500 (-4.3A) | 0.70A | 1muiB-4njvA:20.6 | 1muiB-4njvA:87.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4njv | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 9 | ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30ILE A 47GLY A 49PRO A 81ILE A 84 | RIT A 500 (-2.4A)RIT A 500 (-3.9A)RIT A 500 (-3.6A)RIT A 500 (-3.2A)RIT A 500 (-4.8A)RIT A 500 ( 4.5A)RIT A 500 (-3.4A)RIT A 500 (-3.9A)RIT A 500 (-4.3A) | 0.52A | 1muiB-4njvA:20.6 | 1muiB-4njvA:87.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4njv | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 9 | ASP A 25GLY A 27ALA A 28ASP A 29ILE A 47GLY A 49ILE A 50PRO A 81ILE A 84 | RIT A 500 (-2.4A)RIT A 500 (-3.9A)RIT A 500 (-3.6A)RIT A 500 (-3.2A)RIT A 500 ( 4.5A)RIT A 500 (-3.4A)RIT A 500 (-4.3A)RIT A 500 (-3.9A)RIT A 500 (-4.3A) | 0.49A | 1muiB-4njvA:20.6 | 1muiB-4njvA:87.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4o1e | DIHYDROPTEROATESYNTHASE DHPS (Desulfitobacteriumhafniense) |
PF00809(Pterin_bind) | 5 | ASP A 170GLY A 172ALA A 173PRO A 131ILE A 165 | None | 0.87A | 1muiB-4o1eA:undetectable | 1muiB-4o1eA:16.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4r1u | CINNAMOYL COAREDUCTASE (Medicagotruncatula) |
PF01370(Epimerase) | 5 | GLY A 97ASP A 59GLY A 8VAL A 70ILE A 66 | None | 0.85A | 1muiB-4r1uA:undetectable | 1muiB-4r1uA:13.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4rlb | CARBAPENEM-ASSOCIATED RESISTANCE PROTEIN (Acinetobacterbaumannii) |
no annotation | 6 | GLY A 196ASP A 201GLY A 192ILE A 188VAL A 120ILE A 122 | None | 1.37A | 1muiB-4rlbA:undetectable | 1muiB-4rlbA:16.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wql | 2''-AMINOGLYCOSIDENUCLEOTIDYLTRANSFERASE (Klebsiellapneumoniae) |
PF10706(Aminoglyc_resit) | 5 | ALA A 16ASP A 17ILE A 9VAL A 61ILE A 60 | None | 0.88A | 1muiB-4wqlA:undetectable | 1muiB-4wqlA:21.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xvo | L,D-TRANSPEPTIDASE (Mycolicibacteriumsmegmatis) |
PF03734(YkuD) | 5 | ASP A 107ALA A 91ASP A 88ILE A 84PRO A 63 | None | 0.89A | 1muiB-4xvoA:undetectable | 1muiB-4xvoA:17.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ydf | HTLV-1 PROTEASE (PrimateT-lymphotropicvirus 1) |
PF00077(RVP) | 7 | ARG A 10ASP A 32GLY A 34ALA A 35ASP A 36GLY A 58ILE A 100 | None4B1 A 201 (-2.9A)4B1 A 201 ( 4.6A)4B1 A 201 (-3.6A)4B1 A 201 (-4.4A)4B1 A 201 (-3.4A)4B1 A 201 (-4.8A) | 0.61A | 1muiB-4ydfA:13.1 | 1muiB-4ydfA:31.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4z38 | MLNA (Bacillusvelezensis) |
no annotation | 5 | GLY A 576GLY A 748ILE A 747PRO A 559ILE A 556 | FMN A 900 (-3.5A)NoneNoneNoneNone | 0.87A | 1muiB-4z38A:undetectable | 1muiB-4z38A:13.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5b18 | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 8 | ARG A 8GLY A 27ALA A 28ASP A 29ASP A 30GLY A 49PRO A 81ILE A 84 | None | 1.09A | 1muiB-5b18A:18.0 | 1muiB-5b18A:76.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5elz | TYPE II PANTOTHENATEKINASE (Staphylococcusaureus) |
PF03630(Fumble) | 5 | GLY A 51ALA A 7ILE A 14GLY A 4ILE A 57 | None | 0.88A | 1muiB-5elzA:undetectable | 1muiB-5elzA:19.84 |